Fairvalue-Calculator Fairvalue-Calculator
EN DE

LAC Med Berhad (5341) Fair Value & Analysis

Healthcare · MY · Market cap 286M MYR

Price0.7000 MYR
Fair Value1.05 MYR
Upside+50.0%
Quality91/100
Evidence: High Range 0.7900 MYR – 1.32 MYR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

LAC Med Berhad (5341) currently trades at 0.7000 MYR, while our model-based Fair Value estimate is 1.05 MYR — implying the stock looks roughly 50.0% undervalued today. We read business quality at 91/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

LAC Med Berhad engages in the distribution, supply, and integration of medical devices, diagnostic equipment, and digital health solutions for diagnostic purposes in Malaysia and Indonesia. The company offers diagnostic equipment, radiographic, ultrasound, magnetic resonance imaging (MRI), as well as software systems and maintenance services. It serves hospitals, clinics, and healthcare providers. The company was incorporated in 2003 and is headquartered in Petaling Jaya, Malaysia.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -23% Stryker Corporation (S1YK34) -89% Medtronic plc (MDT) -7% Boston Scientific Corporation (B1SX34) -81% Edwards Lifesciences Corporation (EW) -53% Siemens Healthineers AG (SEMHF) +19%

Frequently asked questions

Is LAC Med Berhad (5341) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 1.05 MYR versus a price of 0.7000 MYR — about +50% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 5341?
Our 21-model fair value for LAC Med Berhad is 1.05 MYR (as of Jun 24, 2026), built from audited fundamentals. The current price is 0.7000 MYR.
What is the quality score of 5341?
LAC Med Berhad has a Quality Score of 91/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.